Vistide (Gilead Sciences, Inc.)
Welcome to the PulseAid listing for the Vistide drug offered from Gilead Sciences, Inc.. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Gilead Sciences, Inc. |
| NON-PROPRIETARY NAME: | CIDOFOVIR |
| SUBSTANCE NAME: | CIDOFOVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-06-26 |
| END MARKETING DATE: | 0000-00-00 |
Vistide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Vistide from Gilead Sciences, Inc. |
| LABELER NAME: | Gilead Sciences, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 75(mg/mL) |
| START MARKETING DATE: | 1996-06-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61958-0101_cc1a8d88-6b17-49dd-9e47-a19a3a4b0f44 |
| PRODUCT NDC: | 61958-0101 |
| APPLICATION NUMBER: | NDA020638 |
Other CIDOFOVIR Pharmaceutical Manufacturers / Labelers:
